When used for treating certain types of cancer, Mutamycin® (mitomycin) works to slow down the progression of the disease by interfering with the process needed for cancer cells to grow and divide. This prescription medicine is specifically approved for treating stomach or pancreatic cancer in adults.
Mutamycin is used when the cancer has not adequately responded to other treatment. It is given as an injection into a vein (intravenously, or by IV) once every six to eight weeks. Most people who use this medicine will experience some type of side effect, such as nausea, vomiting, and hair loss.
Although this drug may help in the treatment of this type of cancer, not everyone can use it. Information on Mutamycin should be discussed with your healthcare provider before starting treatment to minimize your risk for certain complications. For instance, people who have a bleeding disorder or a low blood platelet count may not be able to safely use this medicine.
(Click Mutamycin for more information on this drug, including how it works, possible side effects, and dosing tips on when and how it is given.)
Mutamycin. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2012. Available from Wolters Kluwer Health, Inc. Accessed November 3, 2012.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed November 3, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click